FINWIRES · TerminalLIVE
FINWIRES

Medtronic Positioned for Potential Upside to Fiscal 2027 Guidance, RBC Capital Markets Says

By

Medtronic (MDT) could deliver upside to fiscal 2027 guidance as cardiac ablation, renal denervation, Hugo, Stealth AXiS, and Altaviva momentum support growth, RBC Capital Markets said in a note Wednesday.

Medtronic beat fiscal Q4 estimates, delivering 6.6% organic revenue growth and adjusted earnings of $1.55 per share. Cardiac ablation solutions led the beat, with sales up 78% from a year earlier and US growth of 124%, the brokerage said.

Management's fiscal 2027 guidance came in below consensus, but several growth drivers are improving at the same time, including renal denervation that analysts described as underappreciated, according to the note.

The brokerage said it now models fiscal 2027 adjusted sales growth of 7.1% and adjusted earnings of $5.96 per share.

RBC Capital Markets maintained its outperform rating and $118 price target on the stock.

Shares of Medtronic were up more than 4% in Thursday trading.

Price: $81.58, Change: $+3.63, Percent Change: +4.66%

Related Articles

Wire

Broadcom's AI Revenue Outlook Falls Short of High Bar, RBC Says

Broadcom's (AVGO) Q3 AI revenue outlook likely fell short of investor expectations, while its Q2 results were slightly ahead of consensus, RBC Capital Markets said in a Thursday note.The report said the company's decision to reiterate and not to raise fiscal 2027 AI outlook was also a surprise, especially given the robust demand backdrop."We do not see any structural issues and surmise that power/data center constraints and conservatism are playing a role," the report said."Whatever the case, we expect the stock to remain range bound given limited near-term upside potential, premium valuation to NVDA, and lack of incremental catalysts," it added.RBC raised its price target to $400 from $360, while reiterating its sector perform rating.Price: $414.54, Change: $-64.70, Percent Change: -13.50%

$AVGO
Wire

Figure Technology Secures $250 Million Commitment From Cross River Bank to Support Crypto-Backed Loans

Figure Technology Solutions (FIGR) and Cross River Bank have established a forward-flow agreement under which the bank's Principal Finance Group has committed to purchasing up to $250 million in assets to support Figure's crypto-backed loans, Cross River said Thursday.The agreement provides Figure with committed capital to offer consumers US dollar liquidity without requiring them to sell their cryptocurrency holdings, Cross River said.Through Figure's crypto-backed loan product, borrowers can use their digital assets as collateral to access financing while maintaining ownership of those assets, the company said.Figure Technology shares were 1.5% higher in Thursday trading.Figure Technology Solutions shares were up 2.4% in Thursday trading.Price: $31.76, Change: $+0.78, Percent Change: +2.52%

$FIGR
Wire

CrowdStrike Delivers Strong Q1 on AI Momentum, RBC Says

CrowdStrike Holdings' (CRWD) fiscal Q1 results delivered a strong start to the year as the company boosted guidance for annual recurring revenue after a quarterly beat, supported by AI momentum, RBC Capital Markets said Thursday in a report.The ARR result still fell short of the market's elevated expectations, tied to optimism around the company's Mythos and Glasswing initiatives, the report said. Management raised its full-year ARR outlook by far more than the size of the quarterly beat, reflecting growing confidence in AI-driven demand and the sales pipeline, RBC said."Despite the run in shares, we still favor the name as a cybersecurity consolidator with tangible AI tailwinds and accelerating growth/improving profitability on estimates we believe are still biased upward," the report said.Management described Mythos, the company's new AI-native architecture, as an inflection point. While it did not materially affect Q1 results, it contributed to a record Q2 pipeline and supported the full-year guidance increase, RBC said.AI tailwinds remain strong, with AI-driven detection and response more than tripling from the previous quarter and the Q2 pipeline exceeding $50 million, the report said.RBC raised its price target on CrowdStrike stock to $755 from $650 and maintained its outperform rating.Price: $694.14, Change: $-53.48, Percent Change: -7.15%

$CRWD